Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.

about

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.

Item

http://www.wikidata.org/entity/Q42288648

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@en

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@nl

type

Item

label

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@en

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@nl

prefLabel

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@en

Phase II study of S-1 plus leu ...... imen of 1 week on, 1 week off.

@nl

P1476

Phase II study of S-1 plus leu ...... gimen of 1 week on, 1 week off

@en

P2093

Hideo Baba

http://www.w3.org/2001/XMLSchema#string

Hideyuki Mishima

http://www.w3.org/2001/XMLSchema#string

Jianming Xu

http://www.w3.org/2001/XMLSchema#string

Jinwan Wang

http://www.w3.org/2001/XMLSchema#string

Ken Shimada

http://www.w3.org/2001/XMLSchema#string

Kenji Sakai

http://www.w3.org/2001/XMLSchema#string

Koji Ikejiri

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Manabu Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ruihua Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.

A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.

P304

2045-2051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13335

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Jin Li

P577

2017-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28763145

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5623741

http://www.w3.org/2001/XMLSchema#string